Antibiotic resistance is one of the major health problems of our time. Bacteria and viruses that multiply in human and animal bodies divide...
Antibiotic resistance is one of the major health problems of our time. Bacteria and viruses that multiply in human and animal bodies divide and multiply rapidly.
Their genera change rapidly, and as a result of Darwin's laws of natural excretion, they are able to adapt quickly to their environment, including the ability to quickly develop internal defense against drugs and antibiotics developed by humans.
Which, as a result, will not protect humanity from diseases caused by bacterial and viral infections over time.
One solution to the problem of antibiotic resistance may be to enable the human and animal body to produce antibiotics against which pathogens cannot develop resistance.
This can be accomplished by looking for species in nature that are already capable of producing such antibiotics, then identifying the genes responsible for antibiotic production in these species, and finally genetically modifying these genes into humans and farm animals to produce antibiotics against which pathogens cannot develop resistance.
One such species could be a community of fungal ants that have been shown by scientific observations to be able to produce antibiotics against spores of foreign fungal species that attack fungal species grown in their ant communities against which they are unable to develop resistance.
I therefore recommend the identification of antibiotic-producing genes in fungal ants and their transfer to humans and farm animals to create better transgenic organisms against infectious diseases.
Links:
Ayush Pathak, Steve Kett, Massimiliano Marvasi,
Resisting Antimicrobial Resistance: Lessons from Fungus Farming Ants,
Trends in Ecology & Evolution,
Volume 34, Issue 11,
2019,
Pages 974-976,
ISSN 0169-5347,
https://doi.org/10.1016/j.tree.2019.08.007.
(https://www.sciencedirect.com/science/article/pii/S0169534719302563)
Abstract: Attine ants use antimicrobials produced by commensal bacteria to inhibit parasites on their fungal gardens. However, in this agricultural system, antimicrobial use does not lead to overwhelming resistance, as is typical in clinical settings. Mixtures of continually evolving antimicrobial variants could support these dynamics.
.jpg)
COMMENTS